(firstQuint)Safety and Efficacy of Oral Febuxostat in Subjects With Gout.

 A randomized, double-blind, multicenter, allopurinol-controlled and parallel-assigned study comparing 40 mg, 80 mg of febuxostat, and allopurinol 300 mg in subjects with gout.

 Subjects will receive treatment for 24 weeks.

.

 Safety and Efficacy of Oral Febuxostat in Subjects With Gout@highlight

The purpose of this study is to compare febuxostat allopurinol in subjects with gout.

